Literature DB >> 30138891

Sinomenine protects against E.coli-induced acute lung injury in mice through Nrf2-NF-κB pathway.

Suzi Liu1, Qiuhua Chen2, Junjun Liu1, Xiaoting Yang1, Yan Zhang1, Fengjie Huang3.   

Abstract

Acute lung injury (ALI) is a common disease characterized by pulmonary inflammation and oxidative stress. Sinomenine (SIN) is an alkaloid originally extracted from the Chinese medicinal plant Sinomenium acutum. It has been shown to have anti-inflammatory and anti-oxidative effect. However, it's unclear whether SIN can alleviate ALI. In this study, we assessed the effect of SIN on Escherichia coli (E.coli)-induced ALI mouse model. Mice were conditioned with SIN or placebo 1 h before intratracheally instilled with E.coli. Lung water content, malondialdehyde (MDA) content, superoxide dismutase (SOD) activity, Myeloperoxidase (MPO) levels and inflammatory cytokines production were measured. Immunohistochemistry and western blot were performed to measure target protein expression. E.coli induced histological changes indicating tissues damage and increased W/D ratio, MPO activity, MDA content, and inflammatory cytokines production in the Lung. Whereas in mice pretreated with SIN, these changes were absent. E.coli-induced NF-κB activation was also inhibited by SIN. In addition, SIN increased the expression of HO-1, NQO1 and Nrf2 in lung tissues. Our results suggest that SIN attenuates ALI through the inhibition of inflammation and oxidative stress.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acute lung injury; NF-κB; Nrf2; Sinomenine

Mesh:

Substances:

Year:  2018        PMID: 30138891     DOI: 10.1016/j.biopha.2018.08.048

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Sinomenine Attenuates Cartilage Degeneration by Regulating miR-223-3p/NLRP3 Inflammasome Signaling.

Authors:  Hai-Chao Dong; Pei-Nan Li; Chang-Jian Chen; Xin Xu; Hong Zhang; Gang Liu; Lian-Jie Zheng; Peng Li
Journal:  Inflammation       Date:  2019-08       Impact factor: 4.092

2.  Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-κB-NLRP3 Inflammasome Signaling Pathway.

Authors:  Pelin Aydin; Zeynep Berna Aksakalli Magden; Sevgi Karabulut Uzuncakmak; Hamza Halici; Nurullah Akgun; Ali Sefa Mendil; Behzad Mokhtare; Elif Cadirci
Journal:  Lung       Date:  2022-08-30       Impact factor: 3.777

3.  Pneumonia caused by Mycobacterium tuberculosis.

Authors:  Meili Wei; Jun Xi; Jun Wei; Bikui Tang
Journal:  Microbes Infect       Date:  2020-06-16       Impact factor: 2.700

4.  Sinomenine Inhibits the Growth of Ovarian Cancer Cells Through the Suppression of Mitosis by Down-Regulating the Expression and the Activity of CDK1.

Authors:  Xiaoyan Qu; Bing Yu; Mengmei Zhu; Xiaomei Li; Lishan Ma; Chuyin Liu; Yixing Zhang; Zhongping Cheng
Journal:  Onco Targets Ther       Date:  2021-02-05       Impact factor: 4.147

5.  Sinomenine activation of Nrf2 signaling prevents inflammation and cerebral injury in a mouse model of ischemic stroke.

Authors:  Fangfang Bi; Yiyong Zhang; Wenbo Liu; Keliang Xie
Journal:  Exp Ther Med       Date:  2021-04-18       Impact factor: 2.447

Review 6.  Herbal Active Ingredients: Potential for the Prevention and Treatment of Acute Lung Injury.

Authors:  Wen-Ying Yu; Chun-Xiao Gao; Huan-Huan Zhang; Yue-Guo Wu; Chen-Huan Yu
Journal:  Biomed Res Int       Date:  2021-06-22       Impact factor: 3.411

Review 7.  Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment-From Mice to Men.

Authors:  Andreas von Knethen; Ulrike Heinicke; Volker Laux; Michael J Parnham; Andrea U Steinbicker; Kai Zacharowski
Journal:  Biomedicines       Date:  2022-01-04

8.  Knockout of cytochrome P450 1A1 enhances lipopolysaccharide-induced acute lung injury in mice by targeting NF-κB activation.

Authors:  Li-Xing Tian; Xin Tang; Wei Ma; Jing Wang; Wei Zhang; Kuan Liu; Tao Chen; Jun-Yu Zhu; Hua-Ping Liang
Journal:  FEBS Open Bio       Date:  2020-09-23       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.